

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sperm motility (GO:0030317) | 5.32650977 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.92149609 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.92149609 |
| 4 | acrosome reaction (GO:0007340) | 4.62755656 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 4.60187741 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.60187741 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.56562329 |
| 8 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.35833176 |
| 9 | activated T cell proliferation (GO:0050798) | 4.35243593 |
| 10 | cell wall macromolecule catabolic process (GO:0016998) | 4.24974152 |
| 11 | cell wall macromolecule metabolic process (GO:0044036) | 4.24974152 |
| 12 | interferon-gamma production (GO:0032609) | 4.06841336 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.00483215 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.00483215 |
| 15 | acrosome assembly (GO:0001675) | 3.92133070 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.87839022 |
| 17 | aromatic amino acid family catabolic process (GO:0009074) | 3.84389670 |
| 18 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.75852850 |
| 19 | sperm-egg recognition (GO:0035036) | 3.69144147 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 3.67105741 |
| 21 | calcium ion-dependent exocytosis (GO:0017156) | 3.61014484 |
| 22 | regulation of cilium movement (GO:0003352) | 3.61013508 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.57726354 |
| 24 | plasma membrane fusion (GO:0045026) | 3.52441386 |
| 25 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.52328213 |
| 26 | mast cell activation (GO:0045576) | 3.48484934 |
| 27 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.47681060 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.46978971 |
| 29 | negative regulation of interleukin-12 production (GO:0032695) | 3.46156334 |
| 30 | kynurenine metabolic process (GO:0070189) | 3.39369787 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 3.37966748 |
| 32 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.34461419 |
| 33 | positive regulation of defense response to virus by host (GO:0002230) | 3.33603680 |
| 34 | positive regulation of isotype switching (GO:0045830) | 3.33092742 |
| 35 | organic cation transport (GO:0015695) | 3.31954330 |
| 36 | multicellular organism reproduction (GO:0032504) | 3.31333907 |
| 37 | cell-cell recognition (GO:0009988) | 3.29230360 |
| 38 | tryptophan catabolic process (GO:0006569) | 3.26887325 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 3.26887325 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 3.26887325 |
| 41 | binding of sperm to zona pellucida (GO:0007339) | 3.26691336 |
| 42 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.26254085 |
| 43 | regulation of gamma-delta T cell activation (GO:0046643) | 3.24190244 |
| 44 | urea cycle (GO:0000050) | 3.24163830 |
| 45 | urea metabolic process (GO:0019627) | 3.24163830 |
| 46 | tryptophan metabolic process (GO:0006568) | 3.23344952 |
| 47 | tyrosine metabolic process (GO:0006570) | 3.21830721 |
| 48 | immunoglobulin mediated immune response (GO:0016064) | 3.21392655 |
| 49 | positive regulation of DNA recombination (GO:0045911) | 3.20418931 |
| 50 | bile acid biosynthetic process (GO:0006699) | 3.20008380 |
| 51 | spermatid development (GO:0007286) | 3.18735609 |
| 52 | mast cell degranulation (GO:0043303) | 3.16628061 |
| 53 | mast cell activation involved in immune response (GO:0002279) | 3.16628061 |
| 54 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.14989845 |
| 55 | response to interferon-beta (GO:0035456) | 3.14131515 |
| 56 | high-density lipoprotein particle remodeling (GO:0034375) | 3.13539466 |
| 57 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.13416128 |
| 58 | lactate metabolic process (GO:0006089) | 3.11681995 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 3.10713351 |
| 60 | leukocyte aggregation (GO:0070486) | 3.10341197 |
| 61 | cellular response to interleukin-15 (GO:0071350) | 3.09748903 |
| 62 | positive regulation of B cell mediated immunity (GO:0002714) | 3.08634872 |
| 63 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.08634872 |
| 64 | reproduction (GO:0000003) | 3.06989800 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 3.06530285 |
| 66 | regulation of germinal center formation (GO:0002634) | 3.03285202 |
| 67 | neutrophil activation (GO:0042119) | 3.02655458 |
| 68 | RNA destabilization (GO:0050779) | 3.02304872 |
| 69 | cellular response to interferon-beta (GO:0035458) | 3.00568264 |
| 70 | nitrogen cycle metabolic process (GO:0071941) | 3.00347113 |
| 71 | epithelial cilium movement (GO:0003351) | 2.98150942 |
| 72 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.96986686 |
| 73 | sulfur amino acid catabolic process (GO:0000098) | 2.93190230 |
| 74 | DNA deamination (GO:0045006) | 2.92673083 |
| 75 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.91297043 |
| 76 | leukocyte degranulation (GO:0043299) | 2.90846035 |
| 77 | aromatic amino acid family metabolic process (GO:0009072) | 2.90560179 |
| 78 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.89993728 |
| 79 | fructose metabolic process (GO:0006000) | 2.89500942 |
| 80 | defense response to protozoan (GO:0042832) | 2.89013808 |
| 81 | macroautophagy (GO:0016236) | 2.84663326 |
| 82 | complement activation, alternative pathway (GO:0006957) | 2.83492578 |
| 83 | macrophage activation involved in immune response (GO:0002281) | 2.82261497 |
| 84 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.81620621 |
| 85 | amino-acid betaine metabolic process (GO:0006577) | 2.79990864 |
| 86 | myeloid cell activation involved in immune response (GO:0002275) | 2.79984550 |
| 87 | protein carboxylation (GO:0018214) | 2.79698521 |
| 88 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.79698521 |
| 89 | reverse cholesterol transport (GO:0043691) | 2.78722270 |
| 90 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.78596276 |
| 91 | bile acid metabolic process (GO:0008206) | 2.77542655 |
| 92 | positive regulation of glycolytic process (GO:0045821) | 2.75788370 |
| 93 | response to interleukin-15 (GO:0070672) | 2.75440139 |
| 94 | glyoxylate metabolic process (GO:0046487) | 2.75413216 |
| 95 | protein polyglutamylation (GO:0018095) | 2.74225333 |
| 96 | positive regulation of immunoglobulin production (GO:0002639) | 2.74076173 |
| 97 | regulation of cholesterol esterification (GO:0010872) | 2.73110423 |
| 98 | regulation of microtubule-based movement (GO:0060632) | 2.72291070 |
| 99 | aspartate family amino acid catabolic process (GO:0009068) | 2.71307663 |
| 100 | sperm capacitation (GO:0048240) | 2.71067046 |
| 101 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.69825908 |
| 102 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.69685895 |
| 103 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.69685895 |
| 104 | synaptic vesicle exocytosis (GO:0016079) | 2.69049135 |
| 105 | microglial cell activation (GO:0001774) | 2.68803466 |
| 106 | regulation of regulatory T cell differentiation (GO:0045589) | 2.68631984 |
| 107 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.68464994 |
| 108 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.68360140 |
| 109 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.67871028 |
| 110 | lysine metabolic process (GO:0006553) | 2.67756718 |
| 111 | lysine catabolic process (GO:0006554) | 2.67756718 |
| 112 | cellular modified amino acid catabolic process (GO:0042219) | 2.67752943 |
| 113 | plasma lipoprotein particle remodeling (GO:0034369) | 2.67721263 |
| 114 | protein-lipid complex remodeling (GO:0034368) | 2.67721263 |
| 115 | macromolecular complex remodeling (GO:0034367) | 2.67721263 |
| 116 | cellular response to exogenous dsRNA (GO:0071360) | 2.67438905 |
| 117 | locomotory exploration behavior (GO:0035641) | 2.66962251 |
| 118 | granulocyte activation (GO:0036230) | 2.66571710 |
| 119 | glutamate metabolic process (GO:0006536) | 2.66188357 |
| 120 | coenzyme catabolic process (GO:0009109) | 2.64738001 |
| 121 | indolalkylamine metabolic process (GO:0006586) | 2.64622724 |
| 122 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.64300490 |
| 123 | response to type I interferon (GO:0034340) | 2.63928629 |
| 124 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.63829972 |
| 125 | response to protozoan (GO:0001562) | 2.63366178 |
| 126 | ketone body metabolic process (GO:1902224) | 2.62779832 |
| 127 | regulation of T cell mediated immunity (GO:0002709) | 2.62723289 |
| 128 | leukotriene biosynthetic process (GO:0019370) | 2.62515465 |
| 129 | cellular response to type I interferon (GO:0071357) | 2.62225312 |
| 130 | type I interferon signaling pathway (GO:0060337) | 2.62225312 |
| 131 | regulation of inclusion body assembly (GO:0090083) | 2.62053567 |
| 132 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.61846215 |
| 133 | alpha-amino acid catabolic process (GO:1901606) | 2.61019119 |
| 134 | tolerance induction (GO:0002507) | 2.60030356 |
| 135 | negative regulation of interleukin-1 production (GO:0032692) | 2.59865556 |
| 136 | negative regulation of fibrinolysis (GO:0051918) | 2.59539532 |
| 137 | positive regulation of antigen processing and presentation (GO:0002579) | 2.59481763 |
| 138 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.58691044 |
| 139 | axonemal dynein complex assembly (GO:0070286) | 2.58004227 |
| 140 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.57722427 |
| 141 | regulation of fibrinolysis (GO:0051917) | 2.57260922 |
| 142 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.56970348 |
| 143 | negative regulation of inclusion body assembly (GO:0090084) | 2.56720098 |
| 144 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.56227384 |
| 145 | response to peptidoglycan (GO:0032494) | 2.56185011 |
| 146 | regulation of B cell mediated immunity (GO:0002712) | 2.55795198 |
| 147 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.54871449 |
| 148 | positive regulation of mast cell activation (GO:0033005) | 2.54301655 |
| 149 | regulation of defense response to virus by host (GO:0050691) | 2.53821098 |
| 150 | NAD biosynthetic process (GO:0009435) | 2.53391177 |
| 151 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.52568238 |
| 152 | acylglycerol homeostasis (GO:0055090) | 2.52218133 |
| 153 | triglyceride homeostasis (GO:0070328) | 2.52218133 |
| 154 | negative regulation of sterol transport (GO:0032372) | 2.52160991 |
| 155 | negative regulation of cholesterol transport (GO:0032375) | 2.52160991 |
| 156 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.51838790 |
| 157 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.51345187 |
| 158 | regulation of mast cell activation (GO:0033003) | 2.50978168 |
| 159 | carnitine metabolic process (GO:0009437) | 2.50959421 |
| 160 | cellular amino acid catabolic process (GO:0009063) | 2.50909556 |
| 161 | regulation of isotype switching (GO:0045191) | 2.50848534 |
| 162 | platelet dense granule organization (GO:0060155) | 2.50687638 |
| 163 | regulation of cell killing (GO:0031341) | 2.50683411 |
| 164 | positive regulation of T cell mediated immunity (GO:0002711) | 2.49538936 |
| 165 | regulation of adaptive immune response based on somatic recombination of immune receptors built from | 2.49072805 |
| 166 | cilium movement (GO:0003341) | 2.48684594 |
| 167 | peptidyl-glutamic acid modification (GO:0018200) | 2.48288892 |
| 168 | regulation of antigen processing and presentation (GO:0002577) | 2.47958491 |
| 169 | regulation of lymphocyte mediated immunity (GO:0002706) | 2.47632509 |
| 170 | regulation of protein activation cascade (GO:2000257) | 2.47314463 |
| 171 | motile cilium assembly (GO:0044458) | 2.46462150 |
| 172 | response to pheromone (GO:0019236) | 2.46267463 |
| 173 | regulation of hypersensitivity (GO:0002883) | 2.46183314 |
| 174 | ether metabolic process (GO:0018904) | 2.45698613 |
| 175 | positive regulation of adaptive immune response (GO:0002821) | 2.44787734 |
| 176 | negative regulation of adaptive immune response (GO:0002820) | 2.44701447 |
| 177 | glutamate secretion (GO:0014047) | 2.44552052 |
| 178 | regulation of triglyceride catabolic process (GO:0010896) | 2.44161847 |
| 179 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.44108152 |
| 180 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.43944275 |
| 181 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.43804411 |
| 182 | detection of bacterium (GO:0016045) | 2.42951709 |
| 183 | vocalization behavior (GO:0071625) | 2.41509638 |
| 184 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.41223903 |
| 185 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.40473178 |
| 186 | base-excision repair, AP site formation (GO:0006285) | 2.40387845 |
| 187 | regulation of adaptive immune response (GO:0002819) | 2.40351185 |
| 188 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.39796052 |
| 189 | glycolytic process (GO:0006096) | 2.39608680 |
| 190 | short-chain fatty acid metabolic process (GO:0046459) | 2.38589656 |
| 191 | benzene-containing compound metabolic process (GO:0042537) | 2.38439020 |
| 192 | plasma lipoprotein particle clearance (GO:0034381) | 2.38212357 |
| 193 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.37764720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.08022149 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.13444490 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.07241305 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.34462057 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.05519273 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.96525437 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.84703302 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.81572096 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.81093183 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.67093002 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.66569187 |
| 12 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.64124048 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.58193546 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.50069915 |
| 15 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.46524844 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.41237649 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.39915670 |
| 18 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.33211874 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.26948646 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.26442572 |
| 21 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.18569767 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15401981 |
| 23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.13385408 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.10885504 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.89020755 |
| 26 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.85872664 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.81766830 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.76572254 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.75931799 |
| 30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.75711227 |
| 31 | GATA3_26560356_Chip-Seq_TH2_Human | 1.71361358 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.70493915 |
| 33 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67911581 |
| 34 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.67317529 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67130702 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.66273365 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.64694372 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.64447159 |
| 39 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.61189083 |
| 40 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.61110366 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60824947 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.60603833 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59458637 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.56055174 |
| 45 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.55436592 |
| 46 | MYB_26560356_Chip-Seq_TH2_Human | 1.53956665 |
| 47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.53528612 |
| 48 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.50947471 |
| 49 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.48091338 |
| 50 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.47301786 |
| 51 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.46919791 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.45927548 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44969413 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44328913 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43516319 |
| 56 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.39886636 |
| 57 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.39816543 |
| 58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38730249 |
| 59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37162563 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.36258691 |
| 61 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.33036538 |
| 62 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.31522547 |
| 63 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.29580755 |
| 64 | ERA_21632823_ChIP-Seq_H3396_Human | 1.29560244 |
| 65 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.28450677 |
| 66 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 1.28403504 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28304805 |
| 68 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.28184955 |
| 69 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.28049006 |
| 70 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.27832084 |
| 71 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26700336 |
| 72 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26278122 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25730750 |
| 74 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.25662782 |
| 75 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25491188 |
| 76 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.23451135 |
| 77 | P300_27268052_Chip-Seq_Bcells_Human | 1.22811365 |
| 78 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.22454388 |
| 79 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.22364164 |
| 80 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.21853187 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.20905829 |
| 82 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20570541 |
| 83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.20300987 |
| 84 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.20106459 |
| 85 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19312088 |
| 86 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.17902992 |
| 87 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.17868009 |
| 88 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.17523801 |
| 89 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17215782 |
| 90 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.16503977 |
| 91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.15723068 |
| 92 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.14929929 |
| 93 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.13623129 |
| 94 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.13623129 |
| 95 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13475254 |
| 96 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13281680 |
| 97 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.13217356 |
| 98 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.12140752 |
| 99 | MYB_26560356_Chip-Seq_TH1_Human | 1.10582280 |
| 100 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.10521598 |
| 101 | MAF_26560356_Chip-Seq_TH1_Human | 1.10290064 |
| 102 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08840984 |
| 103 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.08046525 |
| 104 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.08046525 |
| 105 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07888121 |
| 106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07605905 |
| 107 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.07194180 |
| 108 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.06287184 |
| 109 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05603102 |
| 110 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05238164 |
| 111 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05144879 |
| 112 | UTX_26944678_Chip-Seq_JUKART_Human | 1.04668901 |
| 113 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04668310 |
| 114 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04001634 |
| 115 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03898313 |
| 116 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03855835 |
| 117 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.03716324 |
| 118 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03714766 |
| 119 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.03445261 |
| 120 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03358732 |
| 121 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01811413 |
| 122 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.01272584 |
| 123 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.01088322 |
| 124 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01071584 |
| 125 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00958660 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00373576 |
| 127 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.00239145 |
| 128 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.00096899 |
| 129 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00062671 |
| 130 | AR_20517297_ChIP-Seq_VCAP_Human | 0.99653877 |
| 131 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99429505 |
| 132 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98766572 |
| 133 | MAF_26560356_Chip-Seq_TH2_Human | 0.98696566 |
| 134 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.98682602 |
| 135 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.98393092 |
| 136 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98003331 |
| 137 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97212029 |
| 138 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.97042347 |
| 139 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96278600 |
| 140 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96164124 |
| 141 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96164124 |
| 142 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95853346 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.95805465 |
| 144 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95718547 |
| 145 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95599785 |
| 146 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94980798 |
| 147 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.94679061 |
| 148 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94651554 |
| 149 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93954094 |
| 150 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93657674 |
| 151 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.93598059 |
| 152 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.92780222 |
| 153 | STAT3_23295773_ChIP-Seq_U87_Human | 0.92002018 |
| 154 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91921862 |
| 155 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91341960 |
| 156 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91187061 |
| 157 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91187061 |
| 158 | P68_20966046_ChIP-Seq_HELA_Human | 0.91004726 |
| 159 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90743345 |
| 160 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90720916 |
| 161 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90627763 |
| 162 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90527015 |
| 163 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90173442 |
| 164 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.89899146 |
| 165 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.89491617 |
| 166 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89276090 |
| 167 | NCOR_22424771_ChIP-Seq_293T_Human | 0.89071599 |
| 168 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88599398 |
| 169 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.88240136 |
| 170 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87755733 |
| 171 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86823271 |
| 172 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86473129 |
| 173 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86134166 |
| 174 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.84395245 |
| 175 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.83637117 |
| 176 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.83510418 |
| 177 | TCF4_23295773_ChIP-Seq_U87_Human | 0.83244946 |
| 178 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82407651 |
| 179 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.82330697 |
| 180 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.82280867 |
| 181 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.81835148 |
| 182 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.81537710 |
| 183 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.81518034 |
| 184 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.80938195 |
| 185 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.80131602 |
| 186 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.79668469 |
| 187 | AR_19668381_ChIP-Seq_PC3_Human | 0.79667499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005410_abnormal_fertilization | 4.95680511 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.63304564 |
| 3 | MP0005365_abnormal_bile_salt | 3.69653448 |
| 4 | MP0005360_urolithiasis | 3.56477819 |
| 5 | MP0003724_increased_susceptibility_to | 3.50339781 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.46667475 |
| 7 | MP0005671_abnormal_response_to | 3.32688332 |
| 8 | MP0006082_CNS_inflammation | 3.32532556 |
| 9 | MP0003436_decreased_susceptibility_to | 3.16195461 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.90637162 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.83662090 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.82125424 |
| 13 | MP0009785_altered_susceptibility_to | 2.78028898 |
| 14 | MP0004859_abnormal_synaptic_plasticity | 2.53484538 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.52596995 |
| 16 | MP0001800_abnormal_humoral_immune | 2.52194816 |
| 17 | MP0002132_abnormal_respiratory_system | 2.50807049 |
| 18 | MP0000685_abnormal_immune_system | 2.38364701 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.30099898 |
| 20 | MP0005025_abnormal_response_to | 2.29658181 |
| 21 | MP0001790_abnormal_immune_system | 2.28272713 |
| 22 | MP0005387_immune_system_phenotype | 2.28272713 |
| 23 | MP0003195_calcinosis | 2.26598089 |
| 24 | MP0010329_abnormal_lipoprotein_level | 2.26297964 |
| 25 | MP0002723_abnormal_immune_serum | 2.26279134 |
| 26 | MP0002419_abnormal_innate_immunity | 2.26155387 |
| 27 | MP0002909_abnormal_adrenal_gland | 2.24698524 |
| 28 | MP0002822_catalepsy | 2.14035294 |
| 29 | MP0000013_abnormal_adipose_tissue | 2.09614506 |
| 30 | MP0002452_abnormal_antigen_presenting | 2.08585871 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 2.06078456 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 2.05967236 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.98052876 |
| 34 | MP0001819_abnormal_immune_cell | 1.96796276 |
| 35 | MP0003252_abnormal_bile_duct | 1.96429498 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.94120751 |
| 37 | MP0009764_decreased_sensitivity_to | 1.92283748 |
| 38 | MP0004270_analgesia | 1.90451607 |
| 39 | MP0003635_abnormal_synaptic_transmissio | 1.89980016 |
| 40 | MP0003303_peritoneal_inflammation | 1.89705441 |
| 41 | MP0002405_respiratory_system_inflammati | 1.86307447 |
| 42 | MP0005670_abnormal_white_adipose | 1.81854939 |
| 43 | MP0003329_amyloid_beta_deposits | 1.81533879 |
| 44 | MP0001984_abnormal_olfaction | 1.76610053 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.74482442 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.68981766 |
| 47 | MP0003698_abnormal_male_reproductive | 1.68931243 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.67097784 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.61675691 |
| 50 | MP0005332_abnormal_amino_acid | 1.59111203 |
| 51 | MP0001873_stomach_inflammation | 1.57755008 |
| 52 | MP0008469_abnormal_protein_level | 1.55857152 |
| 53 | MP0009840_abnormal_foam_cell | 1.55580811 |
| 54 | MP0002063_abnormal_learning/memory/cond | 1.55034420 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 1.55012379 |
| 56 | MP0009745_abnormal_behavioral_response | 1.53070000 |
| 57 | MP0002118_abnormal_lipid_homeostasis | 1.52338632 |
| 58 | MP0001986_abnormal_taste_sensitivity | 1.51651669 |
| 59 | MP0009046_muscle_twitch | 1.51506219 |
| 60 | MP0004043_abnormal_pH_regulation | 1.51000552 |
| 61 | MP0003283_abnormal_digestive_organ | 1.47665108 |
| 62 | MP0002064_seizures | 1.47414703 |
| 63 | MP0003880_abnormal_central_pattern | 1.46002394 |
| 64 | MP0005083_abnormal_biliary_tract | 1.44600550 |
| 65 | MP0002572_abnormal_emotion/affect_behav | 1.43955206 |
| 66 | MP0005646_abnormal_pituitary_gland | 1.42183848 |
| 67 | MP0000716_abnormal_immune_system | 1.41547890 |
| 68 | MP0003183_abnormal_peptide_metabolism | 1.39718289 |
| 69 | MP0003300_gastrointestinal_ulcer | 1.38917985 |
| 70 | MP0003763_abnormal_thymus_physiology | 1.38306089 |
| 71 | MP0001968_abnormal_touch/_nociception | 1.35321510 |
| 72 | MP0001501_abnormal_sleep_pattern | 1.32968092 |
| 73 | MP0003878_abnormal_ear_physiology | 1.31553801 |
| 74 | MP0005377_hearing/vestibular/ear_phenot | 1.31553801 |
| 75 | MP0002653_abnormal_ependyma_morphology | 1.29122716 |
| 76 | MP0005535_abnormal_body_temperature | 1.29106139 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 1.28610162 |
| 78 | MP0002398_abnormal_bone_marrow | 1.26394128 |
| 79 | MP0006276_abnormal_autonomic_nervous | 1.26139298 |
| 80 | MP0001440_abnormal_grooming_behavior | 1.25158425 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 1.24920245 |
| 82 | MP0005310_abnormal_salivary_gland | 1.24018290 |
| 83 | MP0001502_abnormal_circadian_rhythm | 1.23910667 |
| 84 | MP0002272_abnormal_nervous_system | 1.21502789 |
| 85 | MP0005379_endocrine/exocrine_gland_phen | 1.21265085 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 1.20773850 |
| 87 | MP0005645_abnormal_hypothalamus_physiol | 1.19519437 |
| 88 | MP0005551_abnormal_eye_electrophysiolog | 1.19199384 |
| 89 | MP0002736_abnormal_nociception_after | 1.19184137 |
| 90 | MP0004142_abnormal_muscle_tone | 1.18467782 |
| 91 | MP0000689_abnormal_spleen_morphology | 1.17996519 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 1.16936994 |
| 93 | MP0001929_abnormal_gametogenesis | 1.16391065 |
| 94 | MP0003866_abnormal_defecation | 1.15740065 |
| 95 | MP0002733_abnormal_thermal_nociception | 1.15288261 |
| 96 | MP0002090_abnormal_vision | 1.14054031 |
| 97 | MP0000604_amyloidosis | 1.13899839 |
| 98 | MP0009333_abnormal_splenocyte_physiolog | 1.13783789 |
| 99 | MP0002254_reproductive_system_inflammat | 1.13459684 |
| 100 | MP0001486_abnormal_startle_reflex | 1.11545013 |
| 101 | MP0005075_abnormal_melanosome_morpholog | 1.10905263 |
| 102 | MP0004130_abnormal_muscle_cell | 1.10426223 |
| 103 | MP0009278_abnormal_bone_marrow | 1.10406276 |
| 104 | MP0000569_abnormal_digit_pigmentation | 1.09303916 |
| 105 | MP0004858_abnormal_nervous_system | 1.08200128 |
| 106 | MP0005464_abnormal_platelet_physiology | 1.07767970 |
| 107 | MP0008872_abnormal_physiological_respon | 1.05164970 |
| 108 | MP0003011_delayed_dark_adaptation | 1.04062116 |
| 109 | MP0002234_abnormal_pharynx_morphology | 1.03919420 |
| 110 | MP0003868_abnormal_feces_composition | 1.03032261 |
| 111 | MP0002429_abnormal_blood_cell | 1.02171806 |
| 112 | MP0002722_abnormal_immune_system | 1.01521765 |
| 113 | MP0009697_abnormal_copulation | 1.00553306 |
| 114 | MP0002876_abnormal_thyroid_physiology | 1.00466484 |
| 115 | MP0002735_abnormal_chemical_nociception | 0.99461364 |
| 116 | MP0001666_abnormal_nutrient_absorption | 0.99216073 |
| 117 | MP0000609_abnormal_liver_physiology | 0.99103362 |
| 118 | MP0002933_joint_inflammation | 0.98687594 |
| 119 | MP0003646_muscle_fatigue | 0.98440517 |
| 120 | MP0002557_abnormal_social/conspecific_i | 0.97942889 |
| 121 | MP0003633_abnormal_nervous_system | 0.97536146 |
| 122 | MP0005084_abnormal_gallbladder_morpholo | 0.97250558 |
| 123 | MP0004019_abnormal_vitamin_homeostasis | 0.96518749 |
| 124 | MP0001944_abnormal_pancreas_morphology | 0.96053600 |
| 125 | MP0003045_fibrosis | 0.93610285 |
| 126 | MP0003787_abnormal_imprinting | 0.93355868 |
| 127 | MP0001663_abnormal_digestive_system | 0.93294020 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.91555168 |
| 129 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90414649 |
| 130 | MP0001764_abnormal_homeostasis | 0.90387061 |
| 131 | MP0004947_skin_inflammation | 0.90016994 |
| 132 | MP0005647_abnormal_sex_gland | 0.88832080 |
| 133 | MP0002067_abnormal_sensory_capabilities | 0.88819119 |
| 134 | MP0005319_abnormal_enzyme/_coenzyme | 0.88087747 |
| 135 | MP0002161_abnormal_fertility/fecundity | 0.87835273 |
| 136 | MP0005636_abnormal_mineral_homeostasis | 0.86200580 |
| 137 | MP0001970_abnormal_pain_threshold | 0.85788695 |
| 138 | MP0003953_abnormal_hormone_level | 0.85648953 |
| 139 | MP0003172_abnormal_lysosome_physiology | 0.84723998 |
| 140 | MP0004811_abnormal_neuron_physiology | 0.84569736 |
| 141 | MP0001765_abnormal_ion_homeostasis | 0.84072918 |
| 142 | MP0004233_abnormal_muscle_weight | 0.83970321 |
| 143 | MP0006072_abnormal_retinal_apoptosis | 0.83688645 |
| 144 | MP0003122_maternal_imprinting | 0.83360767 |
| 145 | MP0003075_altered_response_to | 0.82701711 |
| 146 | MP0004883_abnormal_blood_vessel | 0.81786945 |
| 147 | MP0000955_abnormal_spinal_cord | 0.81727925 |
| 148 | MP0000230_abnormal_systemic_arterial | 0.81726191 |
| 149 | MP0004885_abnormal_endolymph | 0.81273838 |
| 150 | MP0002928_abnormal_bile_duct | 0.77666993 |
| 151 | MP0005448_abnormal_energy_balance | 0.77318606 |
| 152 | MP0000703_abnormal_thymus_morphology | 0.76739880 |
| 153 | MP0000639_abnormal_adrenal_gland | 0.76403909 |
| 154 | MP0005397_hematopoietic_system_phenotyp | 0.74975851 |
| 155 | MP0001545_abnormal_hematopoietic_system | 0.74975851 |
| 156 | MP0003879_abnormal_hair_cell | 0.74592172 |
| 157 | MP0005386_behavior/neurological_phenoty | 0.74325445 |
| 158 | MP0004924_abnormal_behavior | 0.74325445 |
| 159 | MP0002069_abnormal_eating/drinking_beha | 0.74289227 |
| 160 | MP0003638_abnormal_response/metabolism_ | 0.74284470 |
| 161 | MP0004510_myositis | 0.73570719 |
| 162 | MP0002066_abnormal_motor_capabilities/c | 0.72997567 |
| 163 | MP0003631_nervous_system_phenotype | 0.71639745 |
| 164 | MP0004085_abnormal_heartbeat | 0.71406154 |
| 165 | MP0000538_abnormal_urinary_bladder | 0.71118127 |
| 166 | MP0003690_abnormal_glial_cell | 0.70672335 |
| 167 | MP0001905_abnormal_dopamine_level | 0.70371938 |
| 168 | MP0000003_abnormal_adipose_tissue | 0.70198284 |
| 169 | MP0002229_neurodegeneration | 0.70057040 |
| 170 | MP0003191_abnormal_cellular_cholesterol | 0.69606139 |
| 171 | MP0005253_abnormal_eye_physiology | 0.69121005 |
| 172 | MP0008961_abnormal_basal_metabolism | 0.69014184 |
| 173 | MP0003828_pulmonary_edema | 0.67637192 |
| 174 | MP0002998_abnormal_bone_remodeling | 0.67520788 |
| 175 | MP0005058_abnormal_lysosome_morphology | 0.66683114 |
| 176 | MP0000858_altered_metastatic_potential | 0.64454031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.02453452 |
| 2 | Myositis (HP:0100614) | 4.99078833 |
| 3 | Absent/shortened dynein arms (HP:0200106) | 4.77929981 |
| 4 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.77929981 |
| 5 | Stomatitis (HP:0010280) | 4.76071086 |
| 6 | Hypoglycemic seizures (HP:0002173) | 4.54124834 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.53606766 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.45912755 |
| 9 | Optic neuritis (HP:0100653) | 4.33517022 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.33517022 |
| 11 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.30836015 |
| 12 | Orchitis (HP:0100796) | 4.09044084 |
| 13 | Hypoglycemic coma (HP:0001325) | 4.04883435 |
| 14 | Ketosis (HP:0001946) | 4.00309387 |
| 15 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.94237286 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.89119198 |
| 17 | Ketoacidosis (HP:0001993) | 3.85071458 |
| 18 | Cholecystitis (HP:0001082) | 3.77472767 |
| 19 | Abnormal gallbladder physiology (HP:0012438) | 3.77472767 |
| 20 | Deep venous thrombosis (HP:0002625) | 3.54524400 |
| 21 | Xanthomatosis (HP:0000991) | 3.43392517 |
| 22 | Abnormality of the intrinsic pathway (HP:0010989) | 3.33341226 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.29163588 |
| 24 | Symptomatic seizures (HP:0011145) | 3.26253250 |
| 25 | Neurofibrillary tangles (HP:0002185) | 3.20124403 |
| 26 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.11952912 |
| 27 | Nasal polyposis (HP:0100582) | 3.05618230 |
| 28 | Keratoconjunctivitis (HP:0001096) | 2.99106268 |
| 29 | Stomach cancer (HP:0012126) | 2.97445106 |
| 30 | Joint hemorrhage (HP:0005261) | 2.95533821 |
| 31 | Hyperlipoproteinemia (HP:0010980) | 2.94012822 |
| 32 | Cerebral inclusion bodies (HP:0100314) | 2.93399292 |
| 33 | Keratoconjunctivitis sicca (HP:0001097) | 2.93036843 |
| 34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.89738834 |
| 35 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.89309246 |
| 36 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.89309246 |
| 37 | Encephalitis (HP:0002383) | 2.87734107 |
| 38 | Hypochromic microcytic anemia (HP:0004840) | 2.85531979 |
| 39 | Focal motor seizures (HP:0011153) | 2.82409239 |
| 40 | Attenuation of retinal blood vessels (HP:0007843) | 2.81809611 |
| 41 | Abnormality of macrophages (HP:0004311) | 2.80622808 |
| 42 | Pheochromocytoma (HP:0002666) | 2.80397386 |
| 43 | Recurrent bacterial skin infections (HP:0005406) | 2.79937785 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.76927222 |
| 45 | Congenital stationary night blindness (HP:0007642) | 2.76842663 |
| 46 | Recurrent fungal infections (HP:0002841) | 2.76057471 |
| 47 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.75634433 |
| 48 | Late onset (HP:0003584) | 2.74484513 |
| 49 | Myokymia (HP:0002411) | 2.73392749 |
| 50 | Abnormality of the nasal mucosa (HP:0000433) | 2.70968072 |
| 51 | Recurrent abscess formation (HP:0002722) | 2.70965404 |
| 52 | Complement deficiency (HP:0004431) | 2.69104602 |
| 53 | Hypobetalipoproteinemia (HP:0003563) | 2.65149521 |
| 54 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.63076312 |
| 55 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.62912837 |
| 56 | Recurrent cutaneous fungal infections (HP:0011370) | 2.62912837 |
| 57 | Eczematoid dermatitis (HP:0000976) | 2.61470710 |
| 58 | Vacuolated lymphocytes (HP:0001922) | 2.60105057 |
| 59 | Infertility (HP:0000789) | 2.58739606 |
| 60 | Abnormality of T cells (HP:0002843) | 2.58717259 |
| 61 | Pulmonary infiltrates (HP:0002113) | 2.57641592 |
| 62 | Pancreatic cysts (HP:0001737) | 2.57521435 |
| 63 | Hemoptysis (HP:0002105) | 2.57023733 |
| 64 | Abnormal gallbladder morphology (HP:0012437) | 2.55939755 |
| 65 | Abnormal ciliary motility (HP:0012262) | 2.55835432 |
| 66 | Hyperventilation (HP:0002883) | 2.53488608 |
| 67 | Myoglobinuria (HP:0002913) | 2.52272624 |
| 68 | Hypoproteinemia (HP:0003075) | 2.51718596 |
| 69 | Epidermoid cyst (HP:0200040) | 2.50995842 |
| 70 | Epileptic encephalopathy (HP:0200134) | 2.48708193 |
| 71 | Vasculitis (HP:0002633) | 2.44842861 |
| 72 | Hypochromic anemia (HP:0001931) | 2.42865532 |
| 73 | Chronic bronchitis (HP:0004469) | 2.42585580 |
| 74 | Rhinitis (HP:0012384) | 2.42528644 |
| 75 | Hyperglycemia (HP:0003074) | 2.41686903 |
| 76 | Gout (HP:0001997) | 2.39950724 |
| 77 | Hyperammonemia (HP:0001987) | 2.39790353 |
| 78 | EEG with generalized epileptiform discharges (HP:0011198) | 2.39267378 |
| 79 | Meningitis (HP:0001287) | 2.38436810 |
| 80 | Mediastinal lymphadenopathy (HP:0100721) | 2.37264793 |
| 81 | IgG deficiency (HP:0004315) | 2.34899254 |
| 82 | Epileptiform EEG discharges (HP:0011182) | 2.34582222 |
| 83 | Recurrent skin infections (HP:0001581) | 2.33834723 |
| 84 | Hypoalphalipoproteinemia (HP:0003233) | 2.33717114 |
| 85 | Skin nodule (HP:0200036) | 2.33663238 |
| 86 | Abnormality of the common coagulation pathway (HP:0010990) | 2.33280545 |
| 87 | Hypsarrhythmia (HP:0002521) | 2.30482868 |
| 88 | Abnormality of glycolipid metabolism (HP:0010969) | 2.30429452 |
| 89 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.30429452 |
| 90 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.30429452 |
| 91 | Neuroendocrine neoplasm (HP:0100634) | 2.30406607 |
| 92 | Abnormal drinking behavior (HP:0030082) | 2.29378561 |
| 93 | Polydipsia (HP:0001959) | 2.29378561 |
| 94 | Hypercholesterolemia (HP:0003124) | 2.29129646 |
| 95 | Hyperglycinemia (HP:0002154) | 2.28901590 |
| 96 | Pancreatic fibrosis (HP:0100732) | 2.27856200 |
| 97 | Hypolipoproteinemia (HP:0010981) | 2.26764385 |
| 98 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.26339328 |
| 99 | Nephronophthisis (HP:0000090) | 2.25735903 |
| 100 | Panhypogammaglobulinemia (HP:0003139) | 2.25322546 |
| 101 | Supranuclear gaze palsy (HP:0000605) | 2.25294478 |
| 102 | Cholelithiasis (HP:0001081) | 2.23737050 |
| 103 | Abnormality of the renal cortex (HP:0011035) | 2.20620404 |
| 104 | Gastrointestinal infarctions (HP:0005244) | 2.20157283 |
| 105 | Severe visual impairment (HP:0001141) | 2.16463617 |
| 106 | Abnormality of the renal medulla (HP:0100957) | 2.15080599 |
| 107 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.13810054 |
| 108 | Abolished electroretinogram (ERG) (HP:0000550) | 2.13687633 |
| 109 | Visual hallucinations (HP:0002367) | 2.12615363 |
| 110 | Keratitis (HP:0000491) | 2.11992030 |
| 111 | Conjugated hyperbilirubinemia (HP:0002908) | 2.11819990 |
| 112 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.11389792 |
| 113 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11242006 |
| 114 | Obstructive lung disease (HP:0006536) | 2.11242006 |
| 115 | 3-Methylglutaconic aciduria (HP:0003535) | 2.11058331 |
| 116 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.10411686 |
| 117 | Abnormality of glycine metabolism (HP:0010895) | 2.10411686 |
| 118 | Abnormality of the lower motor neuron (HP:0002366) | 2.08481285 |
| 119 | Hyperglycinuria (HP:0003108) | 2.08139288 |
| 120 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.07836071 |
| 121 | Status epilepticus (HP:0002133) | 2.07369297 |
| 122 | Focal seizures (HP:0007359) | 2.06681786 |
| 123 | Abnormality of T cell number (HP:0011839) | 2.06007032 |
| 124 | Pustule (HP:0200039) | 2.04188151 |
| 125 | Polyuria (HP:0000103) | 2.02222158 |
| 126 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.00770888 |
| 127 | Severe combined immunodeficiency (HP:0004430) | 1.99631488 |
| 128 | Abnormality of midbrain morphology (HP:0002418) | 1.99165008 |
| 129 | Molar tooth sign on MRI (HP:0002419) | 1.99165008 |
| 130 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.97986428 |
| 131 | Leukocytosis (HP:0001974) | 1.97766131 |
| 132 | T lymphocytopenia (HP:0005403) | 1.97448269 |
| 133 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.96369585 |
| 134 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.95831973 |
| 135 | Increased cerebral lipofuscin (HP:0011813) | 1.95786749 |
| 136 | Fat malabsorption (HP:0002630) | 1.95466212 |
| 137 | Delayed CNS myelination (HP:0002188) | 1.95122549 |
| 138 | Arterial thrombosis (HP:0004420) | 1.94818273 |
| 139 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.94147331 |
| 140 | Generalized aminoaciduria (HP:0002909) | 1.93323122 |
| 141 | Global brain atrophy (HP:0002283) | 1.92885855 |
| 142 | Increased IgM level (HP:0003496) | 1.90984663 |
| 143 | Hemiparesis (HP:0001269) | 1.90367578 |
| 144 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.89857591 |
| 145 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.89857591 |
| 146 | True hermaphroditism (HP:0010459) | 1.87818926 |
| 147 | Enlarged kidneys (HP:0000105) | 1.87214044 |
| 148 | Pulmonary embolism (HP:0002204) | 1.86848644 |
| 149 | Abnormality of the pleura (HP:0002103) | 1.86816801 |
| 150 | Abnormality of purine metabolism (HP:0004352) | 1.86717514 |
| 151 | Anorexia (HP:0002039) | 1.86615338 |
| 152 | Gangrene (HP:0100758) | 1.86522295 |
| 153 | Abnormality of the gallbladder (HP:0005264) | 1.86186148 |
| 154 | Generalized tonic-clonic seizures (HP:0002069) | 1.84249165 |
| 155 | Hyperbilirubinemia (HP:0002904) | 1.84219153 |
| 156 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.83831918 |
| 157 | Type II lissencephaly (HP:0007260) | 1.83601153 |
| 158 | Cerebral hemorrhage (HP:0001342) | 1.83462278 |
| 159 | Asymmetric septal hypertrophy (HP:0001670) | 1.83277961 |
| 160 | Irritability (HP:0000737) | 1.82998066 |
| 161 | Abnormality of complement system (HP:0005339) | 1.82146038 |
| 162 | Chest pain (HP:0100749) | 1.81811065 |
| 163 | Torticollis (HP:0000473) | 1.80705509 |
| 164 | Increased serum ferritin (HP:0003281) | 1.80362907 |
| 165 | Absence seizures (HP:0002121) | 1.79253824 |
| 166 | Sensorimotor neuropathy (HP:0007141) | 1.78849581 |
| 167 | Polyneuropathy (HP:0001271) | 1.78681872 |
| 168 | Spontaneous abortion (HP:0005268) | 1.77433513 |
| 169 | Cerebral edema (HP:0002181) | 1.77027291 |
| 170 | Abnormal urine output (HP:0012590) | 1.76738408 |
| 171 | Prolonged bleeding time (HP:0003010) | 1.76612678 |
| 172 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.75279664 |
| 173 | Thrombocytosis (HP:0001894) | 1.74799025 |
| 174 | Central scotoma (HP:0000603) | 1.74597436 |
| 175 | Vertigo (HP:0002321) | 1.74374035 |
| 176 | Abnormality of iron homeostasis (HP:0011031) | 1.74052186 |
| 177 | Abnormality of eosinophils (HP:0001879) | 1.73464558 |
| 178 | Decreased central vision (HP:0007663) | 1.73194310 |
| 179 | Mitochondrial inheritance (HP:0001427) | 1.72602696 |
| 180 | Episodic fever (HP:0001954) | 1.71473004 |
| 181 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.71432177 |
| 182 | Parakeratosis (HP:0001036) | 1.70704091 |
| 183 | Chronic otitis media (HP:0000389) | 1.70468521 |
| 184 | Decreased circulating renin level (HP:0003351) | 1.70160894 |
| 185 | Autoimmune thrombocytopenia (HP:0001973) | 1.69520639 |
| 186 | Agitation (HP:0000713) | 1.69338897 |
| 187 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.69040494 |
| 188 | Death in childhood (HP:0003819) | 1.68428621 |
| 189 | Retinal atrophy (HP:0001105) | 1.68314902 |
| 190 | Anxiety (HP:0000739) | 1.68294652 |
| 191 | Stroke (HP:0001297) | 1.67331121 |
| 192 | Tetraplegia (HP:0002445) | 1.67240702 |
| 193 | Abnormality of nucleobase metabolism (HP:0010932) | 1.67180863 |
| 194 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.66988759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRKD3 | 5.03348892 |
| 2 | INSRR | 4.27210043 |
| 3 | PDK3 | 3.75558289 |
| 4 | PDK4 | 3.75558289 |
| 5 | TXK | 3.28667666 |
| 6 | MAP4K1 | 3.19866011 |
| 7 | EPHA4 | 3.10990053 |
| 8 | RIPK4 | 2.80133385 |
| 9 | TESK1 | 2.48383462 |
| 10 | NTRK3 | 2.44185543 |
| 11 | ITK | 2.41773659 |
| 12 | TNK2 | 2.38068333 |
| 13 | BCKDK | 2.25889488 |
| 14 | ZAP70 | 2.23497697 |
| 15 | FES | 2.22821729 |
| 16 | IKBKE | 2.21621886 |
| 17 | BLK | 2.10830435 |
| 18 | MAP4K2 | 2.10566290 |
| 19 | PDK2 | 2.08465726 |
| 20 | TBK1 | 2.07118575 |
| 21 | DAPK2 | 2.04454308 |
| 22 | ADRBK2 | 2.04172803 |
| 23 | IKBKB | 2.04006530 |
| 24 | ICK | 1.97937465 |
| 25 | TLK1 | 1.92951057 |
| 26 | GRK6 | 1.92201906 |
| 27 | IRAK4 | 1.90128754 |
| 28 | LMTK2 | 1.89091838 |
| 29 | MAPK15 | 1.86873651 |
| 30 | SYK | 1.81963530 |
| 31 | KIT | 1.77452488 |
| 32 | MAP3K4 | 1.74438494 |
| 33 | MAP3K14 | 1.66967309 |
| 34 | NTRK1 | 1.66093275 |
| 35 | MAP2K4 | 1.57088628 |
| 36 | JAK3 | 1.55372733 |
| 37 | PTK2B | 1.54377189 |
| 38 | MINK1 | 1.51680938 |
| 39 | CASK | 1.48357109 |
| 40 | SIK1 | 1.47307331 |
| 41 | BTK | 1.47003180 |
| 42 | GRK1 | 1.43271973 |
| 43 | MAP3K11 | 1.42551886 |
| 44 | TAOK3 | 1.36983284 |
| 45 | WNK4 | 1.36870846 |
| 46 | STK38 | 1.35786089 |
| 47 | MAP3K9 | 1.34902349 |
| 48 | PHKG2 | 1.34606697 |
| 49 | PHKG1 | 1.34606697 |
| 50 | MAP2K6 | 1.29945853 |
| 51 | CSK | 1.29613757 |
| 52 | LYN | 1.29330119 |
| 53 | TYK2 | 1.27737729 |
| 54 | WNK3 | 1.26428607 |
| 55 | DYRK1B | 1.23969353 |
| 56 | MARK1 | 1.23108888 |
| 57 | MATK | 1.22227830 |
| 58 | ERN1 | 1.21635600 |
| 59 | TEC | 1.18302662 |
| 60 | GRK7 | 1.14989768 |
| 61 | MAPKAPK3 | 1.14049362 |
| 62 | LCK | 1.12441621 |
| 63 | TRIB3 | 1.12196397 |
| 64 | NTRK2 | 1.09728616 |
| 65 | HCK | 1.09661030 |
| 66 | MAP2K7 | 1.08808277 |
| 67 | CAMKK1 | 1.03829028 |
| 68 | ACVR1B | 1.01733014 |
| 69 | DAPK1 | 1.01188312 |
| 70 | TESK2 | 1.00900810 |
| 71 | CSF1R | 1.00555892 |
| 72 | PRKCG | 0.97755984 |
| 73 | MAP2K2 | 0.96436029 |
| 74 | EPHA3 | 0.96262625 |
| 75 | IRAK1 | 0.95568691 |
| 76 | CDK5 | 0.95370854 |
| 77 | SIK2 | 0.95155242 |
| 78 | PAK6 | 0.94689563 |
| 79 | ARAF | 0.94618897 |
| 80 | TYRO3 | 0.93543235 |
| 81 | MAP3K2 | 0.92544871 |
| 82 | MAPK7 | 0.92115816 |
| 83 | MAP3K13 | 0.91861717 |
| 84 | OXSR1 | 0.90219220 |
| 85 | PASK | 0.82253119 |
| 86 | CHUK | 0.82210975 |
| 87 | NME1 | 0.79330052 |
| 88 | MARK3 | 0.78603931 |
| 89 | PDK1 | 0.77813941 |
| 90 | NUAK1 | 0.74022203 |
| 91 | EPHB1 | 0.73616734 |
| 92 | PRKCQ | 0.73517657 |
| 93 | PNCK | 0.73082180 |
| 94 | CAMK1G | 0.72502691 |
| 95 | PDPK1 | 0.72490735 |
| 96 | FRK | 0.72434337 |
| 97 | STK16 | 0.72023070 |
| 98 | PRKG2 | 0.72011394 |
| 99 | SGK223 | 0.71994435 |
| 100 | SGK494 | 0.71994435 |
| 101 | PAK3 | 0.71551742 |
| 102 | FER | 0.71217617 |
| 103 | CDC42BPA | 0.70827596 |
| 104 | TNIK | 0.70665345 |
| 105 | PTK6 | 0.67660412 |
| 106 | WNK1 | 0.67017174 |
| 107 | GRK5 | 0.66747059 |
| 108 | ZAK | 0.66588949 |
| 109 | FGFR4 | 0.65162984 |
| 110 | CAMK2A | 0.65134603 |
| 111 | UHMK1 | 0.64732980 |
| 112 | PIM1 | 0.64502356 |
| 113 | PIK3CG | 0.63641705 |
| 114 | JAK1 | 0.63414969 |
| 115 | TAOK1 | 0.62425927 |
| 116 | FGR | 0.61635820 |
| 117 | KSR2 | 0.60911957 |
| 118 | CDK18 | 0.60712810 |
| 119 | CAMKK2 | 0.60001295 |
| 120 | STK38L | 0.59944498 |
| 121 | JAK2 | 0.58381186 |
| 122 | MUSK | 0.58322041 |
| 123 | MAP2K3 | 0.58158494 |
| 124 | IRAK2 | 0.57954215 |
| 125 | CCNB1 | 0.57734031 |
| 126 | PRKCH | 0.57126274 |
| 127 | SIK3 | 0.56781296 |
| 128 | CDK15 | 0.56724442 |
| 129 | KDR | 0.55172720 |
| 130 | SGK2 | 0.55003883 |
| 131 | BCR | 0.53944894 |
| 132 | PRKCZ | 0.53300060 |
| 133 | MAP3K3 | 0.52705909 |
| 134 | PRKAA2 | 0.52554610 |
| 135 | KSR1 | 0.52252826 |
| 136 | TIE1 | 0.51759735 |
| 137 | BMPR1B | 0.51738532 |
| 138 | STK39 | 0.51432197 |
| 139 | ADRBK1 | 0.51113073 |
| 140 | MAP3K1 | 0.50786859 |
| 141 | PLK2 | 0.50014343 |
| 142 | BMPR2 | 0.49947645 |
| 143 | CDK14 | 0.49746616 |
| 144 | MAPK13 | 0.49581948 |
| 145 | PRKAA1 | 0.48592078 |
| 146 | PRKACG | 0.47644137 |
| 147 | CAMK2D | 0.47562272 |
| 148 | TGFBR2 | 0.46942171 |
| 149 | RET | 0.46909404 |
| 150 | PTK2 | 0.46618484 |
| 151 | CDK11A | 0.46426709 |
| 152 | RPS6KA6 | 0.46422658 |
| 153 | PINK1 | 0.45851672 |
| 154 | DYRK1A | 0.45023424 |
| 155 | CAMK1 | 0.44511357 |
| 156 | MAP2K1 | 0.44088670 |
| 157 | LATS2 | 0.40914643 |
| 158 | CDK19 | 0.39912899 |
| 159 | ABL1 | 0.37301641 |
| 160 | ERBB4 | 0.37047014 |
| 161 | CSNK1A1 | 0.35944260 |
| 162 | MAP3K12 | 0.35693859 |
| 163 | RPS6KA3 | 0.35493777 |
| 164 | SGK3 | 0.35322546 |
| 165 | MAP3K7 | 0.35034086 |
| 166 | PRKCE | 0.34903328 |
| 167 | MARK2 | 0.34602090 |
| 168 | PRKCA | 0.31612553 |
| 169 | IGF1R | 0.31594994 |
| 170 | PRKACA | 0.31043412 |
| 171 | FYN | 0.29774748 |
| 172 | STK11 | 0.29382106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.87797776 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.28192642 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.98066805 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.74869074 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.74592634 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.71259677 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.67523321 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.65367126 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.52720363 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.47748866 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.46990658 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.42444506 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41834703 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.31145290 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.31031360 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.15836458 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.14276427 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.08040608 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 2.05346864 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.03747010 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.95442694 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.95328292 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.94696136 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93598365 |
| 25 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.92951708 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.87596660 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.84083147 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75711292 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.75284933 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.73524358 |
| 31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.73438366 |
| 32 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.72987716 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.72613562 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.69686434 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.66254082 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59703430 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.58535127 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58112024 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56469569 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.51171049 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.50846645 |
| 42 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.49163107 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.48549911 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.42827090 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.39649170 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.37573964 |
| 47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36629344 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34199450 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34099462 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 1.33990784 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.32866346 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30872287 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27488652 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26774359 |
| 55 | Tuberculosis_Homo sapiens_hsa05152 | 1.26527641 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26437445 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 1.24778303 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23498071 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20684631 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20388941 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19456869 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16187098 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16019659 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.14901072 |
| 65 | Malaria_Homo sapiens_hsa05144 | 1.14123944 |
| 66 | Nicotine addiction_Homo sapiens_hsa05033 | 1.13910514 |
| 67 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.11057367 |
| 68 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.10191024 |
| 69 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.09717188 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.09364750 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 1.07568086 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 1.07045356 |
| 73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06744689 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06237969 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.06117627 |
| 76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.05372977 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.05288130 |
| 78 | GABAergic synapse_Homo sapiens_hsa04727 | 1.05040684 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04539065 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.03935149 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.03174961 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.01550300 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.00650854 |
| 84 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99519554 |
| 85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.98616697 |
| 86 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98493824 |
| 87 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98036991 |
| 88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97446600 |
| 89 | Circadian entrainment_Homo sapiens_hsa04713 | 0.96385353 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95669119 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95643316 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94933891 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94019955 |
| 94 | Parkinsons disease_Homo sapiens_hsa05012 | 0.89833319 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.89348896 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.89135169 |
| 97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88643322 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88089932 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.87979192 |
| 100 | Cocaine addiction_Homo sapiens_hsa05030 | 0.85168824 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83446636 |
| 102 | Legionellosis_Homo sapiens_hsa05134 | 0.82849507 |
| 103 | Measles_Homo sapiens_hsa05162 | 0.82071901 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.80143028 |
| 105 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79910628 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.79769432 |
| 107 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77596844 |
| 108 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.77122560 |
| 109 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75560708 |
| 110 | Taste transduction_Homo sapiens_hsa04742 | 0.74912423 |
| 111 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74307973 |
| 112 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.73147148 |
| 113 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.73034611 |
| 114 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72602501 |
| 115 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72331822 |
| 116 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72046035 |
| 117 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.71863618 |
| 118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71499605 |
| 119 | Pertussis_Homo sapiens_hsa05133 | 0.70805405 |
| 120 | Olfactory transduction_Homo sapiens_hsa04740 | 0.70530773 |
| 121 | Renin secretion_Homo sapiens_hsa04924 | 0.70249099 |
| 122 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70230409 |
| 123 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70051557 |
| 124 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69227698 |
| 125 | Influenza A_Homo sapiens_hsa05164 | 0.67938540 |
| 126 | Salivary secretion_Homo sapiens_hsa04970 | 0.67360132 |
| 127 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67270233 |
| 128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67225794 |
| 129 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66499758 |
| 130 | Phagosome_Homo sapiens_hsa04145 | 0.66063259 |
| 131 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65704129 |
| 132 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65138875 |
| 133 | Morphine addiction_Homo sapiens_hsa05032 | 0.63766184 |
| 134 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62866159 |
| 135 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.62621805 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61488738 |
| 137 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56042048 |
| 138 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55961680 |
| 139 | RNA polymerase_Homo sapiens_hsa03020 | 0.55683754 |
| 140 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.54872526 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54443995 |
| 142 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54347105 |
| 143 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.54300392 |
| 144 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53557773 |
| 145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53170360 |
| 146 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52910074 |
| 147 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52295671 |
| 148 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51952725 |
| 149 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51388899 |
| 150 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51081400 |
| 151 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48741257 |
| 152 | Insulin resistance_Homo sapiens_hsa04931 | 0.44253241 |
| 153 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44113019 |
| 154 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42269994 |
| 155 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40822744 |
| 156 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40426984 |
| 157 | Lysine degradation_Homo sapiens_hsa00310 | 0.40399905 |
| 158 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.40396171 |
| 159 | Platelet activation_Homo sapiens_hsa04611 | 0.40224029 |
| 160 | Prion diseases_Homo sapiens_hsa05020 | 0.38824707 |
| 161 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36539910 |
| 162 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34465656 |
| 163 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33885053 |
| 164 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32759669 |
| 165 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32680756 |

